| Financial Year |
March 31 2023 |
| Monetary Funds |
101,937,811.65 |
| Held-for-trading Financial Assets |
453,131,047.67 |
| Notes Receivable |
12,183,882.24 |
| Accounts Receivable |
51,964,798.58 |
| Advances to Suppliers |
8,984,118.42 |
| Other Receivables |
3,871,539.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
140,080,781.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,283,181.98 |
| Total Current Assets |
776,148,880.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
157,285,861.02 |
| Under-construction Projects |
24,263,156.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,170,942.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,800,528.54 |
| Deferred Income Tax Assets |
5,616,144.33 |
| Other Non-Current Assets |
14,051,388.12 |
| Sub-Total of Non-Current Assets |
293,901,588.77 |
| Total Assets |
1,070,050,469.07 |
| Short-Term Loans |
165,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,226,552.76 |
| Accounts Payable |
35,584,976.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,306,980.56 |
| Taxes Payable |
9,637,381.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
306,914.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,855,666.72 |
| Other Current Liabilities |
990,818.04 |
| Sub-Total of Current Liabilities |
244,526,044.23 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,717,929.24 |
| Deferred Income Tax Liabilities |
9,116,457.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,366,498.27 |
| Total Liabilities |
275,892,542.50 |
| Paid-In Capital(Or Share Stock) |
68,000,000.00 |
| Capital Surplus |
454,492,464.99 |
| Surplus Reserve |
29,009,916.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
242,655,545.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
794,157,926.57 |
| Owner's Equity（Stockholder's Equity） |
794,157,926.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,070,050,469.07 |
